Previous research has confirmed that EGFR activation can induce the expression of PD-L1 by EGFR–PI3K–AKT, EGFR–Erk, and EGR–PLC-γ signal pathways in ESCC cell lines [9–11]. The gene discussed is EGFR; the disease is esophageal squamous cell carcinoma.